Fulcrum Asset Management LLP Becton Dickinson & CO Transaction History

Fulcrum Asset Management LLP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 15, 2024	SELL	$225.07 - $246.17 $455,766 - $498,494	-2,025 Closed	0 $0
Q1 2022 May 10, 2022	SELL	$243.64 - $270.48 $252,654 - $280,487	-1,037 Reduced 33.87%	2,025 $504,000
Q3 2021 Oct 19, 2021	BUY	$232.72 - $256.47 $712,588 - $785,311	3,062 New	3,062 $720,000
Q2 2021 Jul 13, 2021	BUY	$232.65 - $254.58 $0 - $0	0 New	0 $717,000
Q2 2021 Jul 12, 2021	SELL	$232.65 - $254.58 $578,367 - $632,885	-2,486 Closed	0 $717,000
Q1 2021 Apr 21, 2021	BUY	$232.09 - $256.88 $576,975 - $638,603	2,486 New	2,486 $557,000

1,738

249M

690K

787K

Ticker BDX
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 285,195,008
Market Cap $65.1B
Description
Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenou...

Get notified when there are updates to the investment portfolio of Fulcrum Asset Management LLP, based on Form 13F filings with the SEC.

Stay updated on Fulcrum Asset Management LLP with notifications on news.